chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Pt by EMS with worsening SOB, reports being sick for 10 days, tested positive for COVID on day prior to admission. R/A sat 82, improved with oxygen. Hx lung CA. lobectomy. Cardiac stent. Subjective fevers.  Patient had second COVID vaccine 1 month ago.  He started to have increasing dyspnea and oxygen requirements beginning 2 weeks ago. He has baseline poor lung function due to COPD.  His oxygen requirement is generally 2 liters at night.  His oxygen saturations, which are generally in the 90s, were noted to be in mid 80s at home.  Also of note, COVID labs were as follows: ESR-22, CRP- 15.6, CK-27, Trop- 20, ferritin - 68, BNP-1119. (Chest CT was done on 3/17 which showed growth of RLL nodular opacity, increased consolidation and GGO around the opacity, unchanged existing pulmonary nodules, and unchanged left hilar LAD). Repeated COVID test had a cycle threshold 18. He was given a dose of prednisone 50 mg and increased his oxygen in the ED with good effect.  His oxygen saturations were 96% on 3L at time of transfer to the floor. Given supplemental O2 via NC with goal SpO2 88-92%. Continued his home COPD inhalers. Completed 5 days remdesivir (3/19-3/23). Patient was given prednisone 50 mg at outside clinic on 3/19 which was changed to dexamethasone 6mg x 6 days (3/19-3/25); steroids discontinued on 3/25 due to continued HTN, lower extremity edema (non-cardiogenic), and agitation. His mental status returned to baseline off dexamethasone.  Discharged home with baseline nocturnal oxygen. He continued to require 0.5-1 liter with activity to maintain sat >90%.  VNA will help to wean this at home.
Started with fever after the Varivax vaccination and on June 15, 2016 chickenpox appeared. My left arm was swollen and burned at the injection site.
Vomiting, poor intake, lethargy on 18APR92; Was taken to Er that afternoon; Had glucose of 62; LDH-228, AST-50, alk phos-1,244;
A couple of weeks after getting the 2nd Moderna vaccine I started noticing a strange uncommon smell. it did not smell like anything I had smelled before. For a while I thought it was something in the house  like a pest that died in the wall, or liquid spill that i wasn't aware of. Eventually I realized that certain things around the house would intensify the smell such as coffee or liquid hand soap. The smell of these items was being altered to smell like something else. As of this date I still have this symptom, although it  varies from day to day. My taste seems ok.
I was fatigue after the vaccination. I did test positive on 02/14/2023 for COVID-19. It felt like a bad sinus infection, postnasal drip, fatigue, ear pain, ear congestion. I also had a fever of 99.3. I then went to the urgent care and provider prescribed PAXLOVID for 5 days. I felt better after a few days. I tested positive for 24 days. I was testing every other day to check COVID-19 test.
First dose of Gardasil was administered. Patient fainted, losing consciousness for 10 seconds with full recovery. Lot # 09284, left arm IM
My mom has the stroke after the vaccine (Unspecified Vaccine); My mom has a stroke for about 3-4 weeks ago and suffering pretty much on the death bed because of the virus vaccination shot; This is a spontaneous report from a contactable consumer reported for mother. A female patient of unknown age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) on unknown date at single dose for covid-19 immunization. Medical history and concomitant medications were not reported. The patient had a stroke after the vaccine for about 3-4 weeks ago (May2021) and suffering pretty much on the death bed because of the virus vaccination shot. The outcome of the event was unknown.  Information on the lot/batch number has been requested
Presents for known COVID+ greater than 1 wk as referral from PCP due to progressive SOB & cough. Admit for bacterial pneumonia, COVID+. Tx: zinc, abx. DC home
This spontaneous report as received from a medical assistant refers to multiple unspecified patients of unknown age and gender. Concurrent conditions and medical history were not reported. On unknown dates the patients were vaccinated with PROQUAD (Merck) (lot # L030587, Expiration date 10-FEB-2017; dose and route were not reported). The vaccines were exposed to 9.8 F for 30 minutes due to a data logger. There was no previous temperature excursion. Concomitant drug was not reported. No adverse effects were reported. This is one of the several reports from the same reporter. Additional information has been requested.
Pain, redness and swelling in left leg.  Kept getting worse.  Went to ER and stayed from July 25-28.  A thrombectomy was performed to remove part of a blood clot from hip area down to ankle.  Patient has to take blood thinners for a minimum of 6 months and wear a compression stocking.    (Also was diagnosed with Type 2 diabetes while in hospital and now has to take insulin shots 4 times a day.)
Pain, redness @ site, sz; treated w/Phenobarb & released; 7 days report from mom states pt doing fine & has no further sx;
Hives, itching, anxiety Tx. Benedryl 50mg IM Epinephrine 0.3mg IM Outcome: Transport to ED by EMS
pt recv vax & w/in 24hr devel redness & pain @ the site of vax;tx w/DPH;
24 hours after MMR, Varivax, Prevnar given, cheeks (face), palms of hands, bottom of feet cherry red.  Temperature 102-104 for next 24 hours. Lethargic, cranky, runny nose.  Face, hands, feeet still get red and has a cough now.
pt recvd vax & 4 days later exp idiopathic hemolytic anemia, emesis, jaundice, anorexia, & leukocytosis; in addtl exp thrombocytosis; hospitalized the same day; treatment consisted of blood transfusions & IV hydration;
Received PNEUMOVAX 12-17-13. That evening stated her right arm became very painful and hurt down to fingertips. She felt as though her joints were locking up. She also had chills and was tremorous all over. On 18th felt better.
Mammogram showed masses in right breast and in axillary lymph node.  Referred for ultrasound and biopsy.
None. 7/15/08 -2pm, spoke with pt. regarding 3rd was givenpt said she knew that
Severe soreness on right side of body, incurred from waist up and down through right arm.
The day after the immunization (10-3-10) tingling in calves, then over next 2 week that resolved but tingling moved up until in buttocks and urinary urgency, then all resolved.
102 degree fever for 24 hours after the shot, along with a sore throat and severe headache.
Trouble swallowing, tingling in lips. patient received Benadryl 50mg PO @11:30am. Symptoms resolved with medications. Patient reported feeling better.
anterior and posterior shoulder soreness and heaviness with numbness noticed to under arm area, running down the underneath part of arm, to elbow, to hand to fingers with numbness and tingling in middle ring and pinky fingers and palm of injected arm. began the evening of the vaccine administration 12/21/21 worsened in the morning of 12/22 throughout the day. Required visit to PCP office for evaluation and safety precaution. today still with swelling in the under arm axilla area, swelling and tenderness under bicep are and numbness tingling still present in right palm and including middle ring and pinky fingers. underarm axilla tenderness, also tightness noticed in right deltoid and under arm area. MOST BOTHERSOME is the 1) swelling and tenderness in right in axilla and numbness running down the under area of arm radiating down into palm and fingers.
pt began having n/v in the evening and then seizures at night. pt does have seizure history but does not usually have breakthrough seizures.
Patient received dose 1 of the Pfizer COVID vaccine (FD0809, exp 10/21) at approximately 1025. At 1736, patient reported swelling of the upper lip and gum to RN vaccinator who relayed the information to PHN and Paramedic. Patient denied shortness of breath and difficulty swallowing. No observable swelling noted by PHN. Patient sat down, laying supine, in zero-gravity chair. Vital signs: blood pressure 116/76, O2 98%, pulse 76, respirations 16. Patient reported that she had eaten and drank fluids prior to vaccination. Patient denied allergies but reported taking fish oil and collagen supplements. Patient denied medical conditions apart from status-post back, abdomen, and left forearm surgeries 4 months ago after motor vehicle accident. PHN offered patient Benadryl, patient declined. At 1754, vital signs: respirations 16, O2 97%, pulse 80, blood pressure 110/72. PHN advised patient to follow up with provider, when to call EMS, and waiting for 30min monitoring after report of symptoms. Patient reported no change in symptoms, no worsening. At 1757, patient left walking with steady gait against medical advice.
This spontaneous report was receivd from a pharmacist and refers to unspecified number of patients of unknown age and gender. The patients' medical histories and concurrent conditions were not reported. On an unknown date, the patients were administered ZOSTAVAX post supported temperature excursion (0.65ml, subcutaneously, lot # L000450, expiration date: 09-MAR-2016). No adverse effects were reported. Additional information has been requested.
During the end of May, sudden swelling of foot, continually worsened to the point of being unable to walk. Needed a wheelchair, went to hospital, initially told it was cellulitis, given medicine and sent home, but continued to worsen went back and was admitted to hospital, given antibiotics but did not help, hospitalized for 9 days due to antibiotics. Hospital was Medical Center. Given 500 mg cephalexin, did not help.  Told it was gout after they decided it was not cellulitis, but was not gout. Skin breaking from swelling, would alternate feet for swelling. Given medication for gout that starts with an A (cannot remember name), did not help. Last time I was hospitalized from July 4th to July 8th, still lingering. Doctors still unsure of what it was. The symptoms began to subside somewhat, but still painful. In August still going away, but still having pain in feet and can have flareups.
Left sided Bell's Palsy starting 12 March with numbness and change in the taste in his mouth.  By Sunday, March 14 she started to develop left sided facial weakness, particularly his mouth.  He denied any drooping on his mouth and noted some drooping near his nostril.  He was also unable to move his eyebrows on that side.  Starting on Monday, March 15 he began to have difficulties closing his left eyelid.
I woke up with a runny nose, stuffed up nose, congested, very mild sore throat with a mild cough. I felt groggy and decided to take a COVID-19 home test. I was not waking up like a normally do. The results were positive and I made a telehealth appointment with my Dr. and he prescribed Paxlovid and I am on my last day of that medication. Thursday night was the worst, I felt ok for most of the day but when evening came around that evening the sinus pressure was bad and I had a hard time sleeping and the body aches had come on. Friday, I had the same symptoms and was tired most of the day.  Today I feel pretty much normal. The Dr. said I could leave the house today but not without a mask. I have not taken another home test but plan on doing one tomorrow or Wednesday.
She received the vaccine and rested for 20 minutes.  Left the room and about 10 minutes after she left (30 min post vaccination) she stated her heart was racing, she was nauseous, and her throat felt itchy.  Rapid response RN was called and she was taken to onsite ED for evaluation
Nausea and diarrhea. She was vomiting and fainted in the kitchen floor hitting the wall and making a hole. The nausea and diarrhea have decreased but still feels bad.
Redness, swelling at injection site day after injection. To give Benadryl by mouth every 8 hrs. as needed.
Information has been received from a certified medical assistant referring to a 29 year old male patient. The patient's medical history included born premature. The patient's relevant past drug history included receiving the initial "Hep B" injection when he was born. On 22-JUL-2015, the patient was accidentally given one injection of PEDVAXHIB (dose and route unknown, lot number K019700, expiration date 16-JUL-2017). He had no relevant concomitant medications. On 22-Jul-2015, the medical assistant stated that she meant to give the patient a "Hep B" injection but grabbed the wrong vial. She might maybe they looked similar but when she went back to look, they didn't. No adverse reactions had been noted in the patient. It was unknown if any relevant lab work had been done. As of 22-JUL-2015, it was unknown if the patient would continue on the PEDVAXHIB and the outcome of receiving the PEDVAXHIB injection was unknown. Additional information has been requested.
The patient went to the doctor on 7/16/19 due to adverse events from the vaccine.The patient had a local reaction (swelling, redness) at the injection site that just started to go away on 7/16/19. She developed a splotchy rash on her anterior shin and had extreme chapped lips. She had increased sun sensitivity when she was outside and developed swelling of the lips and face. She was given erythromycin 2% gel and prednisone 40 mg for 3 days. As of 7/25, she returned to the doctor because there was no improvement in her symptoms. She was prescribed a taper of prednisone and pimecrolimus 1% cream. She also developed two bumps on her lateral neck.
Per patient's husband, the patient had difficulty moving her arms, legs and hands. The patient also experienced some discomfort in these extremities. The patient contacted her physician who instructed her to go to the emergency room.
Swollen Arm, Redness, Pain, Itchy at site.   Iced the site, started day after vaccination and has gotten better as of 3/25/21 swelling is less and redness has gone down considerably.
PATIENT REPORTED SLIGHT TIGHTNESS IN HER THROAT.  NEVER EXPERIENCED LOSS OF CONSCIOUSNESS OR CONSTRICTION OF AIRWAY.
received Menveo reconstituted with a different diluent; received Menveo reconstituted with a different diluent; This case was reported by a other health professional via call center representative and described the occurrence of wrong solution used in drug reconstitution in a patient who received Men ACWY-CRM NVS (Menveo) (batch number AMVA714A, expiry date unknown) for prophylaxis.   On an unknown date, the patient received Menveo. On an unknown date, unknown after receiving Menveo, the patient experienced wrong solution used in drug reconstitution and inappropriate dose of vaccine administered. On an unknown date, the outcome of the wrong solution used in drug reconstitution and inappropriate dose of vaccine administered were unknown.   Additional Information: GSK Receipt Date: 02-DEC-2022 Reporter's comment: The practice manager reported that while doing inventory a vial of Menveo diluent was found and the patient just received a dose of Menveo powder portion of Menveo reconstituted with a different diluent. It was assumed that one of three possible patients had received just the powder portion of Menveo reconstituted with a different diluent.  There was no data on the administration date, patient's identifiers or confirmation that the above situation had occurred. The vaccine administration facility was the same as primary reporter. The reporter did not consent to follow up. Additional supportive information: The patient received dose of Menveo powder reconstituted with different diluent, which led to wrong solution used in drug reconstitution and inappropriate dose of vaccine administered.
On February 15, 2022, I began to develop wheals on torso, arms, thighs, groin, buttocks.  Discomfort became severe, I did become short of breath, wheals spread to entire body despite use of H1 and H2 blockers.  Call placed to ordered Prednisone 10mg BID for 5 days, and Hydroxyzine 25mg.
Initial report received on 07 June 2007 from another manufacturer, report# WAES0705USA05073. The initial reporter to this manufacturer had been the FDA, VAERS# not provided. Verbatim from the report: "Information has been received from an agency concerning a 13 year old female with an allergy to cats (the patient owns a cat) who on 22-FEB-2007 was vaccinated intramuscularly into the right arm with a dose of Gardasil (Lot# 655205/1426F). Concomitant therapy included MENACTRA (Lot# U2158AA) in the left arm, HAVRIX (Lot# AHABV141AA) in the right arm and NASONEX. On 22-FEB-2007, 30 minutes after receiving the vaccines, the patient developed cough, wheezing and shortness of breath. The patient was seen in the emergency department for an allergic reaction to the vaccines. Initially, the patient returned to her primary care physician with complaints of chest tightness, difficulty breathing and tremors. The patient was treated with EPI-PEN and BENADRYL and sent to the emergency room. There was no swelling of the mouth, lips or tongue. Vital signs were performed and the patient had a pulse of 141, respiratory rate of 20 and blood pressure of 130/91. The patient was treated with SOLU-MEDROL and Ranitidine. A physical exam was unremarkable (lungs clear, no rhonchi, no wheezes). The patient was admitted to the hospital for IV steroid treatment. At the time of this report, the outcome was unknown. Cough, wheezing, shortness of breath, chest tightness, difficulty breathing, allergic reaction to vaccines and tremors were considered to be immediately life-threatening. The original reporting source was not indicated. A lot check has been requested. No further information is available." It was reported in the structured filed of the report that all vaccines were administered intramuscularly.
This spontaneous report was received from a registered nurse, referring to an unspecified number of patients of unknown demographics. The patients' medical history, concurrent conditions and concomitant medications were not reported. On unspecified dates, the patients were vaccinated with an improperly stored dose of PNEUMOVAX 23 lot # N034525 with expiration date 13-SEP-2019 (dose, route, and anatomical location were not provided) or could have received a dose of ROTATEQ orally,  lot # reported as N012751 with expiration date 27-JAN-2019, (dose and anatomical location were not provided); both used for prophylaxis. The vaccines experienced a temperature excursion of 47 degrees Fahrenheit (°F) to 77 degrees Fahrenheit (°F) with an average temperature of 59.2 degrees Fahrenheit (°F) for 5 hours and 35 minutes. There was no previous temperature excursion. There were no adverse effects reported. It was reported that this call was due to a digital data logger. Lot number N012751 is an invalid lot number for rotavirus vaccine, live, oral, pentavalent.
Pfizer covid 19 vaccine was mixed with 1.4 ml instead of 1.8 ml of diluent. Spoke to patient 04/11/2021 and she reported having a mild fever and a sore arm. Provided counseling.
pt given DTP/OPV/HIB on 20OCT92; on PM of 20OCT92 pt became very fussy, t106; taken to hosp told to give APAP & defer getting DTP give DT & next visit;
Site: Pain at Injection Site-Medium, Systemic: Abdominal Pain-Medium, Systemic: Chest Tightness / Heaviness / Pain-Medium, Systemic: Headache-Medium, Systemic: Nausea-Medium, Systemic: Numbness (specify: facial area, extremities)-Medium, Systemic: Vomiting-Medium, Additional Details: Patients states she cannot lift arm more than 45 degrees, difficulty breathing secondary to chest tightness.
Left thigh swelling, redness, warmth.  Quite significant swelling extending to knee.  Patient is recovering.
COVID-19; COVID-19; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 67-year-old male patient received BNT162b2 (BNT162B2), on 25Jan2021 at 16:30 as dose 1, single (Lot number: Cdr01413171), in right arm and on 15Feb2021 at 13:30 as dose 2, single (Lot number: Cdr0413180) at the age of 65 years, in right arm for covid-19 immunisation. The patient had no relevant medical history. There were no concomitant medications. The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant) all with onset 2022, outcome "not recovered" and all described as "COVID-19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (2022) positive. Therapeutic measures were taken as a result of vaccination failure, covid-19. Clinical course: No other medication in 2weeks and no known allergies. Treatment medication for COVID 19 was Paxlovid and the treatment start date was on 07Jul2022 and the treatment stop date was on 11Jul2022.  Follow-up attempts are completed. No further information is expected.
Diarrhea; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (Diarrhea) in an adult female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.    Co-suspect product included non-company product ADALIMUMAB (HUMIRA) solution for injection for Hidradenitis suppurativa.    No Medical History information was reported.   On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form and ADALIMUMAB (HUMIRA) (Subcutaneous) Citrate free. On an unknown date, the patient experienced DIARRHOEA (Diarrhea). At the time of the report, DIARRHOEA (Diarrhea) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       It was unknown if patient was enrolled in a COVID-19 Vaccine Trial. No concomitant medications were reported. No treatment medications were reported.  This case was identified as part of a retrospective clean-up activity where certain emails received in the Moderna mailbox were missed to be booked-in.
Redness, swelling, and tenderness at injection site.  Slight induration to area.  Given CEPHALEXIN 500 mg three times a day.
body akes,earake,headake,tired,sour arm and Swollen lymph nodes under left arm is the are i got the shot
Initial report received on 18 June 2012 from the Investigator participating in the post-marketing observational surveillance study under the reference number M5A16. A case of pertussis disease in a seven-month-old female subject was identified by the investigator based on review of data from the Electronic Disease Surveillance (EDSS) electronic database. The subject had received 3 doses of PENTACEL; received on 05 December 2011, 06 February 2012 and 10 April 2012 (lot numbers, routes and sites of administration not reported). The subject developed a cough on 20 May 2012, approximately 40 days after the last dose and a paroxysmal cough on 26 May 2012 without a whoop. The subject also experienced posttussive vomiting and sleep disturbance. Laboratory testing included positive PCR on 26 May 2012. Chest x-ray findings were negative for pneumonia. Corrective treatments consisted of azithromycin starting on 28 May 2012 for 5 days. The subject was not hospitalized. At the time of final contact on 06 June 2012, the subject's cough was still persisting. The duration of the cough was reported at that time as 17 days. Investigator causality assessment is not required as per protocol. Documents held by sender: None.
Persistent Bilateral leg pain, bilateral muscle stiffness and weakness. Bilateral  knee pain, left knee worse than right. Bilateral ankle pain.
I noticed around noon on Sat. 11/15/03 that my bicep not only hurt, but was sensitive to touch. By that evening red streaks had started from armpit to below the elbow. By morning, sensitivity was great and streaks were angry They continued below the elbow.
Information was received from a registered nurse referring to a patient of unknown age and gender. The patient's medical history, concurrent condition and concomitant therapy were not reported. On 17-NOV-2015 the patient received the 1st dose of the series with RECOMBIVAX HB (dose unknown) intramuscularly. The 2nd dose was administered on 17-DEC-2015. The patient was to receive the 3rd dose of RECOMBIVAX HB (lot # L048229, expired on 31-MAY-2018) at the reporting day, 27-JUL-2016. (product use issue). No adverse effect was reported. Additional information has been requested.
body aches, fever, chills, nausea, vomiting, decreased appetite; treated with tylenol, motrin, zofran, pedialyte, rest